National Center for Advancing Translational Sciences

Organisation

Awards made

Sarah Beth Lieber
R03Subjective Cognitive Dysfunction in Adults with Systemic Lupus Erythematosus Across the LifespanR03TR0058202026–202814 Sept 2026reporter.nih.gov
Hospital for Special Surgery
R03Subjective Cognitive Dysfunction in Adults with Systemic Lupus Erythematosus Across the LifespanR03TR005820US$179k2026–202814 Sept 2026reporter.nih.gov
Darrell N. Kotton
T32CTSA Predoctoral T32 at Boston UniversityT32TR0053112026–203124 Aug 2026reporter.nih.gov
Matthew Robert Jones
T32CTSA Predoctoral T32 at Boston UniversityT32TR0053112026–203124 Aug 2026reporter.nih.gov
Boston University Medical Campus
T32CTSA Predoctoral T32 at Boston UniversityT32TR005311US$332.8k2026–203124 Aug 2026reporter.nih.gov
Carrie German
UG3An Organ-on-Chip Approach to Evaluation of Reproductive Health, Aging and Disease inWomenUG3TR0058572025–202814 Aug 2026reporter.nih.gov
Cfd Research Corporation
UG3An Organ-on-Chip Approach to Evaluation of Reproductive Health, Aging and Disease inWomenUG3TR005857US$986.6k2025–202814 Aug 2026reporter.nih.gov
Ahmed Nabil Zobi
R44Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue MicrosizingR44TR0049752025–202711 Aug 2026reporter.nih.gov
Syntr Health Technologies, Llc
R44Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue MicrosizingR44TR004975US$1m2025–202711 Aug 2026reporter.nih.gov
John Ramunas
R44Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinicR44TR0053282024–20275 Aug 2026reporter.nih.gov
Rejuvenation Technologies, Inc.
R44Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinicR44TR005328US$1.1m2024–20275 Aug 2026reporter.nih.gov
CHUNHAI Charlie HAO
R21Molecular Glue Degraders Targeting APP for Prevention and Treatment of Down Syndrome-Associated DementiaR21TR0064602026–20283 Aug 2026reporter.nih.gov
Indiana University Indianapolis
R21Molecular Glue Degraders Targeting APP for Prevention and Treatment of Down Syndrome-Associated DementiaR21TR006460US$435.9k2026–20283 Aug 2026reporter.nih.gov
Kevin G Volpp
RC2Research Redesign to Reduce Chronic Conditions in FamiliesRC2TR0061212026–20303 Aug 2026reporter.nih.gov
Alexander Gabriel Fiks
RC2Research Redesign to Reduce Chronic Conditions in FamiliesRC2TR0061212026–20303 Aug 2026reporter.nih.gov
University of Pennsylvania
RC2Research Redesign to Reduce Chronic Conditions in FamiliesRC2TR006121US$3.3m2026–20303 Aug 2026reporter.nih.gov
Floyd Taub
R43uProcess: A novel home and lab system to improve cfDNA screening and monitoring using transrenal DNAR43TR0059282026–20273 Jul 2026reporter.nih.gov
Aigene, Inc.
R43uProcess: A novel home and lab system to improve cfDNA screening and monitoring using transrenal DNAR43TR005928US$349.9k2026–20273 Jul 2026reporter.nih.gov
Nikhil S. Joshi
R44Development of a novel tool that standardizes and automates the formulation of cell-laden hydrogelsR44TR0051122024–202816 Jun 2026reporter.nih.gov
Cellular Vehicles Inc.
R44Development of a novel tool that standardizes and automates the formulation of cell-laden hydrogelsR44TR005112US$1m2024–202816 Jun 2026reporter.nih.gov

Funded papers

Harmonizing the National Lung Screening Trial: Kernel resolution and field of view compensation
UL1TR000445, UL1TR0022435 Oct 2026api.crossref.org
Diet Composition Modifies Cardiometabolic Phenotype Development in the 4-Vinylcyclohexene Dioxide (VCD) Ovarian Failure Model of Menopause
UL1TR0014361 Oct 2026api.crossref.org
Numeracy and recall of Alzheimer's disease risk information: Effects of risk format in a Latino community
UL1TR00187330 Sept 2026api.crossref.org
Cardio-metabolic biomarkers including circulating ketone bodies and risk of incident atrial fibrillation in the multi-ethnic study of atherosclerosis (MESA)
UL1TR000040, UL1TR001420, UL1TR00107930 Sept 2026api.crossref.org
Efficacy of Tailored Messages for 28-Week Exercise Sustainability in People with HIV
UM1TR00439930 Sept 2026api.crossref.org
A high intensity vs. casual speed walking intervention to reverse frailty among older adults: a cluster randomized controlled trial
UL1TR00142230 Sept 2026api.crossref.org
Hearing Loss Prevalence Among Older US Adults: HRS 2016 to 2018 Hearing Screener Data
KL2TR001854, UL1TR00185529 Sept 2026api.crossref.org
A reproducible pipeline for processing commercial wearable step-count data in aging cohorts: Application and evaluation in the STRRIDE-PD reunion study
UL1TR00255324 Sept 2026api.crossref.org
Association of immune-inflammatory markers with chronic kidney disease in older adults with obesity: a large-scale cross-sectional study
R21TR00202424 Sept 2026pubmed.ncbi.nlm.nih.gov
Sleep-disordered breathing, sleep duration, and 24-hour ambulatory blood pressure in subjective short-sleeping adults
UL1TR002538, UM1TR00440921 Sept 2026api.crossref.org
Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C)
18 Sept 2026api.crossref.org
Prefrontal hemodynamic alterations during resting state and stroop interference in cognitively healthy older adults with high plasma pTau-217 levels
UL1TR00185517 Sept 2026api.crossref.org
Diet patterns are associated with progression of coronary artery calcification and differ across race/ethnicity: The Multi-Ethnic Study of Atherosclerosis
UL1TR000040, UL1TR001420, UL1TR0010799 Aug 2026api.crossref.org

Papers

Development and external validation of a contrastive learning foundation model for ECG-based prediction of cardiovascular diseases and outcomes
The Lancet. Digital health1 Sept 2026